Your browser doesn't support javascript.
loading
Kidney Paired Donation Chains Initiated by Deceased Donors.
Wang, Wen; Leichtman, Alan B; Rees, Michael A; Song, Peter X-K; Ashby, Valarie B; Shearon, Tempie; Kalbfleisch, John D.
  • Wang W; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
  • Leichtman AB; Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Rees MA; Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Song PX; Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Ashby VB; Department of Urology, University of Toledo Medical Center, Toledo, Ohio, USA.
  • Shearon T; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA.
  • Kalbfleisch JD; Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, Michigan, USA.
Kidney Int Rep ; 7(6): 1278-1288, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35685310
ABSTRACT

Introduction:

Rather than generating 1 transplant by directly donating to a candidate on the waitlist, deceased donors (DDs) could achieve additional transplants by donating to a candidate in a kidney paired donation (KPD) pool, thereby, initiating a chain that ends with a living donor (LD) donating to a candidate on the waitlist. We model outcomes arising from various strategies that allow DDs to initiate KPD chains.

Methods:

We base simulations on actual 2016 to 2017 US DD and waitlist data and use simulated KPD pools to model DD-initiated KPD chains. We also consider methods to assess and overcome the primary criticism of this approach, namely the potential to disadvantage blood type O-waitlisted candidates.

Results:

Compared with shorter DD-initiated KPD chains, longer chains increase the number of KPD transplants by up to 5% and reduce the number of DDs allocated to the KPD pool by 25%. These strategies increase the overall number of blood type O transplants and make LDs available to candidates on the waitlist. Restricting allocation of blood type O DDs to require ending KPD chains with LD blood type O donations to the waitlist markedly reduces the number of KPD transplants achieved.

Conclusion:

Allocating fewer than 3% of DD to initiate KPD chains could increase the number of kidney transplants by up to 290 annually. Such use of DDs allows additional transplantation of highly sensitized and blood type O KPD candidates. Collectively, patients of each blood type, including blood type O, would benefit from the proposed strategies.
Palabras clave